These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7473478)

  • 1. Hydroxychloroquine in the treatment of erosive osteoarthritis.
    Bryant LR; des Rosier KF; Carpenter MT
    J Rheumatol; 1995 Aug; 22(8):1527-31. PubMed ID: 7473478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.
    Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR
    Trials; 2014 Oct; 15():412. PubMed ID: 25348033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial.
    Kingsbury SR; Tharmanathan P; Adamson J; Arden NK; Birrell F; Cockayne S; Dickson J; Doherty M; Dziedzic KS; Grainger A; Hewitt CE; O'Neill TW; Scott DL; Vincent TL; Wakefield RJ; Watt FE; Torgerson DJ; Conaghan PG
    Trials; 2013 Mar; 14():64. PubMed ID: 23452375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study.
    Saviola G; Abdi-Ali L; Campostrini L; Sacco S; Baiardi P; Manfredi M; Mannoni A; Benucci M
    Mod Rheumatol; 2012 Apr; 22(2):256-63. PubMed ID: 21853386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis: A Randomized Trial.
    Kingsbury SR; Tharmanathan P; Keding A; Ronaldson SJ; Grainger A; Wakefield RJ; Arundel C; Birrell F; Doherty M; Vincent T; Watt FE; Dziedzic K; O'Neill TW; Arden NK; Scott DL; Dickson J; Garrood T; Green M; Menon A; Sheeran T; Torgerson D; Conaghan PG
    Ann Intern Med; 2018 Mar; 168(6):385-395. PubMed ID: 29459986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erosive or inflammatory osteoarthritis: the great unknown].
    Contreras Blasco MA
    Med Clin (Barc); 2007 Jul; 129(7):262-6. PubMed ID: 17683709
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
    Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
    Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine to Reduce Symptoms of Hand Osteoarthritis.
    Ann Intern Med; 2018 Mar; 168(6):. PubMed ID: 29459946
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
    Momose Y; Arai S; Eto H; Kishimoto M; Okada M
    J Dermatol; 2013 Feb; 40(2):94-7. PubMed ID: 23216212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erosive hand osteoarthritis].
    Van Linthoudt D; Gabay C; So AK
    Rev Med Suisse; 2013 Mar; 9(377):569-70, 572, 574-5. PubMed ID: 23534244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lee W; Ruijgrok L; Boxma-de Klerk B; Kok MR; Kloppenburg M; Gerards A; Huisman M; Hazes M; de Sonnaville P; Grillet B; Weel A; Basoski N
    Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1320-1325. PubMed ID: 29125901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients.
    Bili A; Sartorius JA; Kirchner HL; Morris SJ; Ledwich LJ; Antohe JL; Dancea S; Newman ED; Wasko MC
    J Clin Rheumatol; 2011 Apr; 17(3):115-20. PubMed ID: 21441823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
    Kedor C; Detert J; Rau R; Wassenberg S; Listing J; Klaus P; Braun T; Hermann W; Weiner SM; Buttgereit F; Burmester GR
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34215704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
    Siebuhr AS; Bay-Jensen AC; Jordan JM; Kjelgaard-Petersen CF; Christiansen C; Abramson SB; Attur M; Berenbaum F; Kraus V; Karsdal MA
    Scand J Rheumatol; 2016; 45(2):87-98. PubMed ID: 26484849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis.
    Wildy KS; Wasko MC
    Hand Clin; 2001 May; 17(2):321-38, xi. PubMed ID: 11478054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.
    Magnano MD; Chakravarty EF; Broudy C; Chung L; Kelman A; Hillygus J; Genovese MC
    J Rheumatol; 2007 Jun; 34(6):1323-7. PubMed ID: 17516620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
    Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM
    J Rheumatol; 2000 Mar; 27(3):623-9. PubMed ID: 10743799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
    Pope JE; Prashker M; Anderson J
    J Rheumatol; 2004 Jan; 31(1):140-9. PubMed ID: 14705233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).
    Alarcón GS; McGwin G; Bertoli AM; Fessler BJ; Calvo-Alén J; Bastian HM; Vilá LM; Reveille JD;
    Ann Rheum Dis; 2007 Sep; 66(9):1168-72. PubMed ID: 17389655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.